Single Point Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Single Point Partners's NVO Position: Q2 2023 in Review
Single Point Partners sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 4,456 shares — an estimated $355K sold.
Single Point Partners first reported a position in NVO in Q2 2022 and held it in 3 quarters. The position peaked at $355K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- Single Point Partners reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
- Single Point Partners sold 4,456 Novo Nordisk shares in Q2 2023, an estimated $355K.
- Single Point Partners first reported a position in Novo Nordisk in Q2 2022 and held it in 3 quarters.
- Single Point Partners's Novo Nordisk position peaked at $355K in Q1 2023.
- 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on Single Point Partners's 13F filing for Q2 2023, filed 10 Jul 2023.